Experimental agents for the treatment of atherosclerosis: New directions

dc.contributor.author	Voutyritsa, Errika
dc.contributor.author	Kyriakos, Georgios
dc.contributor.author	Patsouras, Alexandros
dc.contributor.author	Damaskos, Christos
dc.contributor.author	Garmpi, Anna
dc.contributor.author	Diamantis, Evangelos
dc.contributor.author	Garmpis, Nikolaos
dc.contributor.author	Savvanis, Spyridon
dc.date.accessioned	2025-11-20T12:50:38Z
dc.date.available	2025-11-20T12:50:38Z
dc.date.issued	2021
dc.identifier.citation	Voutyritsa E, Kyriakos G, Patsouras A, Damaskos C, Garmpi A, Diamantis E, et al. Experimental Agents for the Treatment of Atherosclerosis: New Directions. JEP. febrero de 2021;Volume 13:161-79.
dc.identifier.issn	1179-1454
dc.identifier.uri	https://sms.carm.es/ricsmur/handle/123456789/21829
dc.language.iso	eng
dc.publisher	Dove Medical Press Ltd
dc.rights	Atribución-NoComercial 3.0 No portada
dc.rights.uri	http://creativecommons.org/licenses/by-nc/3.0/	*
dc.title	Experimental agents for the treatment of atherosclerosis: New directions
dc.type	info:eu-repo/semantics/article
dc.relation.publisherversion	https://www.dovepress.com/experimental-agents-for-the-treatment-of-atherosclerosis-new-direction-peer-reviewed-article-JEP
dc.identifier.doi	10.2147/JEP.S265642
dc.journal.title	Journal of Experimental Pharmacology